Business

Krill A/S have developed a revolutionary new way to extract fish oli on. The method make sure that the proteins do not get damaged. Krill A/S have furthermore executed and patent advanced clinical biotechnological research on the University of Southern Denmark and on a danish hopital.

Patent applications

Krill A/S have submitted patent applications, which covering production technology and the biologically research.

Management

Krill A/S were in 2006 by the owners SVD A/S, NOVI A/S and JB Holding ApS sold to the Norwegian industry giant Aker. SVD A/S is still represented in the changed company's board of directors (CardicMed A/S) under Aker Biomarine.